![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1608005927.png\")
<\/p>\n<\/p>\n
<\/strong>Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions<\/em><\/p>\n Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI \/ MMR and TILs Testing, 2019–2030<\/a>.”<\/p>\n The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain. Amongst various elements, the report includes:<\/p>\n Type of test<\/strong><\/p>\n Type of disease indication<\/strong><\/p>\n Type of cancer biomarker<\/strong><\/p>\n Type of analytical technique<\/strong><\/p>\n Key geographical regions<\/strong><\/p>\n Key companies covered in the report<\/a><\/p>\n For more information please click on the following link:<\/p>\n https:\/\/www.rootsanalysis.com\/reports\/view_document\/cancer-biomarkers-market-focus-on-tmb-msi–mmr-and-tils-testing-2019–2030\/253.html<\/a><\/p>\n Other Recent Offerings<\/strong><\/p>\n About Roots Analysis<\/strong><\/p>\n Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n Tags: Anlysis<\/a>, Novel<\/a>, Roots Analysis<\/a>, pharma<\/a>, Immuno-Oncology<\/a>, Biomarker<\/a>, market reports<\/a>, Testing<\/a>, Diagnostics<\/a>, report<\/a>, market<\/a>, cancer<\/a>, biotech<\/a>, Research<\/a><\/p>\n Tags:<\/b> Gaurav Chaudhary\n
\n
\n
\n
\n
\n
\n
\n
See Campaign: <\/strong>https:\/\/www.rootsanalysis.com\/reports\/view_document\/cancer-biomarkers-market-focus-on-tmb-msi–mmr-a<\/a>
Contact Information:<\/b>
Gaurav Chaudhary
\ngaurav.chaudhary@rootsanalysis.com
\nRoots Analysis
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n
<\/a>, Reportedtimes<\/a>, IPS<\/a>, Wire<\/a>, Extended Distribution<\/a>, iCN Internal Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\ngaurav.chaudhary@rootsanalysis.com
\nRoots Analysis
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":" Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI \/ MMR and … Continue reading Cancer biomarkers market for TMB, MSI \/ MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis<\/span><\/a> Continue Reading